Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IKBKB | O14920 | 1/20 | 0.37 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.37 |
| ▸ | RAPGEF4 | Q8WZA2 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | RXRA | P19793 | 1/20 | 0.31 |
| ▸ | RXRB | P28702 | 1/20 | 0.31 |
| ▸ | PGK1 | P00558 | 1/20 | 0.30 |
| ▸ | PGK2 | P07205 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17570537 | 0.84 | NOTUM (0.44) | IKBKBNOTUMRAPGEF4RXRARXRB | |
| SCHEMBL26375581 | 0.79 | NOTUM (0.41) | IKBKBNOTUMRAPGEF4RXRARXRB | |
| SCHEMBL26568305 | 0.78 | KIF11 (0.40) | — | |
| SCHEMBL24254767 | 0.76 | IKBKB (0.41) | IKBKBNOTUMRAPGEF4TDP1RXRA | |
| SCHEMBL26375583 | 0.74 | NOTUM (0.43) | IKBKBNOTUMRAPGEF4TDP1 | |
| SCHEMBL17555046 | 0.74 | IKBKB (0.43) | IKBKBTDP1RXRARXRB | |
| SCHEMBL26375464 | 0.74 | NOTUM (0.50) | IKBKBNOTUMRAPGEF4RXRARXRB | |
| SCHEMBL13949153 | 0.72 | NOTUM (0.49) | IKBKBNOTUMRAPGEF4RXRARXRB | |
| SCHEMBL24254714 | 0.70 | RXRA (0.41) | IKBKBTDP1RXRARXRB | |
| SCHEMBL12583263 | 0.70 | RAPGEF4 (0.48) | IKBKBNOTUMRAPGEF4RXRARXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11793069-B2 | Electron-accepting compound and composition for charge-transporting film, and luminescent element using same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11793069-B2 | Electron-accepting compound and composition for charge-transporting film, and luminescent element using same | SLC26A3, SLC6A19, SLC29A1 | IKBKB 4798/4885NOTUM 4079/4885RAPGEF4 1693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.